Artificial Intelligence meets Head and Neck Oncology

Artificial intelligence is becoming more and more important in medicine and its applications have the capacity to impact oncology largely and how we will care for our patients in the future.
The European Head and Neck Society (EHNS) together with the CHUV/UNIL/EPLF in Lausanne and IEEE Life Science, endorsed as well by ESTRO and YO-IFOS/SSORL, has therefore created a meeting that will focus on artificial Intelligence and its impact on health care in general, cancer prevention, robotic surgery, radiotherapy, pathology, radiology, and the development of systemic treatment for head and neck cancers.
On the first day, we will address the «safety issues» of AI for health care in general and afterward move to AI in cancer prevention, endoscopy, and robotics. On this day we will finish with an exciting discussion of head and neck oncology experts on where to take AI in head and neck oncology in the future.
On the second day, we will address AI in radiation therapy and pathology, followed by AI for imaging and drug development. At the end of the second day, we will discuss during a round table, how AI could be applied to clinical trials and improve systemic head and neck cancer treatment in the future. Register here.